INTRODUCTION
Endotoxin tolerance was first defined as a reduced pyrogenic response in rabbits to an endotoxin challenge following previous lipopolysaccharide (LPS) injections. 1 Later, it was shown that endotoxin tolerance was associated with a profound reduction of tumor necrosis factor (TNF) levels in plasma of tolerized animals after LPS challenge. 2 The involvement of glucocorticoids was demonstrated in adrenalectomized mice 3 and, using cell transfer experiments, the central role played by macrophages was established. 4 Subsequent studies showed the possibility of tolerizing isolated monocytes or macrophages in in vitro experiments. All authors agree that endotoxin tolerance significantly affects the capacity of monocytes/macrophages to produce TNF. In contrast, the reports on the effect of LPS tolerance on the capacity of isolated cells to produce other types of cytokines in vitro are quite controversial. Interleukin-1 production was found to be either enhanced, 5 unaffected, 6 or reduced. 7 Interleukin-6 levels were found to be enhanced 8, 9 or reduced, 7 and similar divergent observations were reported for IL- 10 10,11 and IL-12. 12, 13 . These controversial in vitro results may reflect various experimental procedures, including different amounts of LPS used for tolerization and different types of cells or cell lines. In contrast, LPS tolerization performed in in vivo or ex vivo models was essentially linked with a reduced production of IL-1 in rabbits, 14 mice, 15 and humans. 16 Similarly, IL-6 production was reduced after tolerance induction in rats, 17 guinea pigs, 18 mice, 19 and humans. 16, 20 . Levels of IL-8, IL-10, interferon (IFN) and colony stimulating factors were also reduced following in vivo tolerization. 15 ,20Ð22 Sepsis could represent a pathophysiological situation during which endotoxin tolerance may occur, and it was regularly reported that septic patients have a reduced ex vivo capacity to produce IL-1, IL-6, TNF, IL-10 and IL-12. [23] [24] [25] Many cytokines are induced in vivo following LPS injection and can be measured in plasma. CC and CXC chemokines play a major role in the initiation and the Endotoxin tolerance was induced in mice following one, two or three injections of low amounts of lipopolysaccharide (LPS) before a further LPS injection, and circulating cytokines were analyzed 1.5 h and 3 h after LPS challenge. Three different patterns of cytokine production were obtained. In a first group of cytokines, including tumor necrosis factor (TNF), interleukin-6 (IL-6) and gamma interferon (IFN-γ), the reduction of plasma peak levels was already significantly pronounced after one tolerizing injection of LPS. The second group of cytokines includes the CC chemokine KC, the CXC chemokine monocyte-chemo-attractant protein-1 (MCP-1) and IL-12. The plasma levels of these cytokines were modestly reduced, and the reduction was more pronounced with increasing numbers of tolerizing injections of LPS. The third group of cytokines includes IL-1β and IL-18, the levels of which 3 h after LPS challenge (i.e. at the peak timing) remained essentially similar to those of control mice and after 1.5 h were even enhanced. Altogether, these data illustrate that, in tolerized animals, in vivo regulation of cytokine production differs greatly among different mediators and that immunoparalysis is not a general state. Furthermore, despite the presence of large amounts of IL-12 and IL-18, IFN-γ was essentially suppressed in tolerized animals.
perpetuation of the inflammatory process, associated with an essential role in fighting infection. 26, 27 Similarly, IL-12 and IL-18, cytokines involved in the production of IFN-γ, have recently been identified as key cytokines during infection. 28, 29 To our knowledge, very little is known about the production of both types of chemokines and of IL-12 and IL-18 in an in vivo tolerant state. Therefore, it was of interest to investigate the different profiles of IL-12, IL-18, the CC chemokine KC and the CXC chemokine monocyte chemo-attractant protein-1 (MCP-1) in comparison with TNF, IL-6, IFN-γ and IL-1β in mice which have been tolerized following one, two or three LPS injections. Our data show that induction of LPS tolerance leads to different patterns following LPS challenge depending on the nature of the circulating cytokines.
MATERIALS AND METHODS

Animals and induction of endotoxin tolerance
Six to seven-week-old male BALB/c mice (Charles River, St Aubin les Elbeuf, France) were bred under standard conditions and received food and water ad libitum. Mice were rendered tolerant by i.v. injection of 2.5 µg Escherichia coli LPS (O111:B4) (Sigma-Aldrich, St Quentin Fallavier, France) in saline (0.1 ml) once daily for one, two or three subsequent days. Control mice were injected with the same volume of saline. Control and tolerized mice were challenged by an i.v. injection of 100 µg E. coli LPS, 24 h after the last injection of LPS used for tolerization.
Measurement of cytokines in the plasma
Blood samples were collected by cardiac puncture 1.5 h and 3 h after LPS challenge. After blood sampling, mice were sacrificed by cervical dislocation. Plasma samples were prepared individually and stored frozen at Ð40¡C until assayed for the concentration of cytokines using enzyme-linked immunosorbent assay (ELISA) kits purchased from R&D Systems (Abingdon, UK; IFN-γ, TNFα, IL-6, IL-1β, IL-12, KC and MCP-1) and from Medical & Biological Laboratories, Co. Ltd (Nagoya, Japan; IL-18). The cytokine concentrations were determined by comparison with an internal standard according to the manufacturerÕs instructions. All samples were individually tested, and the results are expressed as mean ± SEM. In preliminary experiments, TNF activity and IL-6 activity were assessed using the cytotoxic bioassay with the WEHI-164 cl.13 cell line and the IL-6 dependent 7TD1 cell line, respectively, as previously described.
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Statistical analysis
Statistical analyses were performed using the non-parametric Mann-Whitney test using the StatView II program for Macintosh.
RESULTS
Mice were tolerized with low amounts of LPS (2.5 µg) either one, two or three times before receiving an LPS injection of 100 µg LPS. Plasma levels of cytokines were analyzed 1.5 h and 3 h after LPS challenge. The timing was based on other reports which established that the peak level of TNF was observed at 1.5 h after LPS challenge, while the levels of most other cytokines peak after 3 h. As shown in Figure 1 , one injection of LPS 24 h before the LPS challenge essentially abolished the capacity of mice to produce high levels of circulating TNF as measured 1.5 h after the challenge. Three hours after LPS challenge, low levels of circulating TNF were detectable in control mice. The levels 3 h after LPS challenge were identical in the control animals and after one tolerizing injection, while two and three tolerizing injections were associated with a reduction of the 3 h TNF levels. One tolerizing injection of LPS only led to a 50% reduction of plasma IL-6 when measured 1.5 h after LPS challenge, whereas the reduction reached 88% when the measurement of IL-6 was performed at 3 h. Additional injections for tolerization further reduced the levels of circulating IL-6 measured after LPS challenge. Experiments determining TNF and IL-6 bioactivity in plasma led to similar results (data not shown). IFN-γ levels were extremely low at 1.5 h, whereas high levels were detected after 3 h in control mice. One injection of LPS was sufficient to essentially abolish the IFN-γ production.
The analysis of the chemokine KC and MCP-1 production after induction of endotoxin tolerance and in response to LPS challenge led to comparable patterns: one injection of LPS used for tolerization was not sufficient to significantly alter the 1.5 h levels of the chemokines after LPS challenge, whereas after 3 h, the levels were reduced. Additional injections of LPS used for tolerization further diminished the levels 1.5 h and 3 h after LPS challenge. Early and peak levels of IL-12 induced by an LPS challenge were not affected by a single injection of LPS used for inducing tolerance. Further tolerizing injections did not significantly modify the early levels of IL-12, whereas the peak levels of IL-12 were significantly reduced after 2 or 3 tolerizing injections of LPS.
Finally, measurements of both IL-1β and IL-18 resulted in quite similar patterns. Endotoxin tolerization resulted in an enhanced early production of these two cytokines 1.5 h after LPS challenge, whereas peak levels observed in control mice 3 h after LPS challenge were not, or only marginally, affected.
DISCUSSION
This is, to our knowledge, the first report where eight different cytokines were simultaneously measured in the plasma of tolerized animals. Our study demonstrates that endotoxin tolerance induced in vivo does not affect the release of cytokines in response to an LPS challenge in a similar fashion. Thus, the production of TNF, IL-6 and IFN-γ was profoundly impaired following induction of LPS tolerance, and one injection of LPS used to induce tolerance was sufficient to lead to a major decrease of the production of these cytokines following LPS challenge. This observation is in agreement with previous observations, 15, 19 although in previous studies, four injections of LPS were performed to induce LPS tolerance. It is worth noting that, in an earlier investigation, only interferon bioactivity had been assessed, 15 whereas more recently, plasma IFN-γ and IFN-γ mRNA expression in the spleen were analyzed. 31 Interestingly, while IFN-γ production was essentially abolished by one tolerizing injection of LPS, this unique pretreatment reduced neither IL-12 nor IL-18 production in response to LPS challenge. Early levels of IL-12 and IL-18 following LPS challenge were not reduced if the number of LPS injections used for induction of tolerance was doubled or tripled. A significant increase of IL-18 was even observed in tolerized animals, independently of the number of LPS injections performed for induction of tolerance. This observation indicates that, despite the presence of high levels of IL-12 and IL-18 which are known to be involved in the signalling of IFN-γ induction, 32 tolerized animals failed to produce IFN-γ. In a similar study, Balkhy and Heinzel 31 reported that mice tolerized by two injections of LPS generated 5Ð8-fold less IL-12 after a challenge dose compared with control mice. In contrast to our study, they used a 20-fold larger amount of tolerizing LPS twice, performed late measurements of IL-12 after challenge (4 h) and did not analyze early production of IL-12. Interestingly, these authors demonstrated that spleen cells from tolerized mice were less responsive to IL-12 and IL-18 than cells from control mice. The absence of TNF, which is known to be involved in IFN-γ production 33 and the reduction of NK cells in tolerized animals, 31 could explain the severe impairment of IFN-γ production in LPS tolerized animals despite the presence of large amounts of both IL-12 and IL-18. The analysis of IL-1β production reveals similar patterns as those observed in the case of IL-18. The peak levels of IL-1β and IL-18, 3 h after LPS challenge, remained essentially unchanged in tolerized animals. The quite similar patterns of IL-1β and IL-18 are of interest since these two cytokines are processed to their mature form by the same converting enzyme, i.e. caspase 1. 34 Thus, it would be of interest to determine the consequences of endotoxin tolerization on caspase 1 activity. Our data, on the consequence of endotoxin tolerance on plasma IL-1 following an LPS challenge, are in agreement with the results reported by Zuckerman et al. 35 but differ from those of Erroi et al. 15 Furthermore, in contrast to our observation in this mouse model, experiments performed in human volunteers 36, 37 or in septic patients 23, 38 showed a reduction of the ex vivo production of IL-1. However, this may well reflect two different mechanisms, one associated with in vivo IL-1 production due to the potential contribution of different types of cells, and the other restricted to the ability of circulating mononuclear cells to produce IL-1 in ex vivo experiments.
To our knowledge, the effect of LPS tolerance on the level of chemokines in plasma of LPS-challenged mice has not been previously addressed. We demonstrate here that both CC and CXC chemokines are affected in a similar fashion. The intensity of the reduction of KC and MCP-1 levels was dependent on the number of injections of LPS used for tolerization. In humans, a decrease of the production of IL-8, a CC chemokine, has also been reported. 16, 36, 39 Modifications of intracellular mechanisms have been associated with endotoxin tolerance. These include a reduction of membrane GTPase and G protein activity, 40 ,41 a reduction of MAP kinase activity, 42 and an altered relative expression of both forms of NF-κB expression. 43, 44 . Altogether, our results suggest that the consequences of these events may not be similar for TNF, IL-6 and IFN-γ induction on the one hand and IL-1β and IL-18 on the other. However, we make this statement with great caution, as most of our knowledge on intracellular mechanisms associated with endotoxin tolerance have been obtained following analysis of in vitro LPS tolerance. These observations do not imply that similar mechanisms occur in vivo. Finally, large amounts of IL-12, IL-18, IL-1β, and to a lesser degree, KC and MCP-1, could be obtained in the absence of large amounts of TNF. These results parallel those we obtained in TNFα/lymphotoxin-α deficient mice, in which, despite the absence of TNF, the levels of IL-12, IFN-γ and nitric oxide were higher than in control mice during a fungal infection. 45 Altogether, our observations further illustrate that the production of TNF is not a prerequisite for the formation and release of other cytokines as previously suggested by experiments using anti-TNF antibodies. 46, 47 Furthermore, our results illustrate that endotoxin tolerance is not a general state of immunoparalysis.
